Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 15, Issue 8, Pages 1097-1107
Publisher
Informa Healthcare
Online
2014-03-27
DOI
10.1517/14656566.2014.903924
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A2A receptor antagonists do not induce dyskinesias in drug-naive or l-dopa sensitized rats
- (2013) N. Jones et al. BRAIN RESEARCH BULLETIN
- Istradefylline: First Global Approval
- (2013) Rosselle Dungo et al. DRUGS
- Suitability of the adenosine antagonist istradefylline for the treatment of Parkinson's disease: pharmacokinetic and clinical considerations
- (2013) Thomas Müller Expert Opinion on Drug Metabolism & Toxicology
- Adenosine A2Areceptor antagonist istradefylline reduces daily OFF time in Parkinson's disease
- (2013) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- In vitro pharmacological profile of the A2A receptor antagonist istradefylline
- (2013) Mayumi Saki et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in l-DOPA-treated parkinsonian monkeys
- (2013) Nicolas Morin et al. NEUROPHARMACOLOGY
- Antidepressant-like activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents
- (2013) Koji Yamada et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex
- (2013) Takako Kadowaki Horita et al. PSYCHOPHARMACOLOGY
- Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease
- (2013) Nandakumar S. Narayanan et al. REVIEWS IN THE NEUROSCIENCES
- An Update on Adenosine A2A Receptors as Drug Target in Parkinson's Disease
- (2012) Antoni Vallano et al. CNS & Neurological Disorders-Drug Targets
- Adenosine A2A Antagonists in Parkinson’s Disease: What’s Next?
- (2012) Patrick Hickey et al. Current Neurology and Neuroscience Reports
- Istradefylline, an adenosine A2A receptor antagonist, for patients with Parkinson's Disease: A meta-analysis
- (2012) Wanqiang Chen et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Caffeine for treatment of Parkinson disease: A randomized controlled trial
- (2012) R. B. Postuma et al. NEUROLOGY
- Istradefylline for the treatment of Parkinson's disease
- (2011) Ariane Park et al. EXPERT OPINION ON PHARMACOTHERAPY
- Population Pharmacokinetic-Pharmacodynamic Analysis of Istradefylline in Patients With Parkinson Disease
- (2011) William Knebel et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Istradefylline for Parkinson's disease patients experiencing motor fluctuations: Results of the KW-6002-US-018 study
- (2011) Emmanuelle Pourcher et al. PARKINSONISM & RELATED DISORDERS
- Key Modulatory Role of Presynaptic Adenosine A2AReceptors in Cortical Neurotransmission to the Striatal Direct Pathway
- (2011) César Quiroz et al. TheScientificWorldJOURNAL
- Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinsonʼs Disease
- (2010) Santiago Perez-Lloret et al. CNS DRUGS
- Population Pharmacokinetic Analysis of Istradefylline in Healthy Subjects and in Patients With Parkinson's Disease
- (2010) William Knebel et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Quantification of Indirect Pathway Inhibition by the Adenosine A2a Antagonist SYN115 in Parkinson Disease
- (2010) K. J. Black et al. JOURNAL OF NEUROSCIENCE
- Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: A randomized, controlled study
- (2010) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism
- (2010) E.J. Nunes et al. NEUROSCIENCE
- Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease
- (2010) K. Xu et al. NEUROSCIENCE
- A long-term study of istradefylline in subjects with fluctuating Parkinson's disease
- (2010) Stewart Factor et al. PARKINSONISM & RELATED DISORDERS
- Effects of the adenosine A2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide
- (2009) A.J. Betz et al. NEUROSCIENCE
- Adenosine, adenosine A2A antagonists, and Parkinson's disease
- (2009) P. Jenner et al. PARKINSONISM & RELATED DISORDERS
- Istradefylline as monotherapy for Parkinson disease: Results of the 6002-US-051 trial
- (2009) H.H. Fernandez et al. PARKINSONISM & RELATED DISORDERS
- Pramipexole effects on startle gating in rats and normal men
- (2009) Neal R. Swerdlow et al. PSYCHOPHARMACOLOGY
- Adenosine A2Areceptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)
- (2008) Peter A. LeWitt et al. ANNALS OF NEUROLOGY
- An Update on Adenosine A2A-Dopamine D2 Receptor Interactions: Implications for the Function of G Protein-Coupled Receptors
- (2008) S. Ferre et al. CURRENT PHARMACEUTICAL DESIGN
- A Study of the Pharmacokinetic Interaction of Istradefylline, a Novel Therapeutic for Parkinson's Disease, and Atorvastatin
- (2008) N. Rao et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations
- (2008) Robert A. Hauser et al. MOVEMENT DISORDERS
- A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease
- (2008) M. Stacy et al. NEUROLOGY
- Dopamine D2 and Adenosine A2A Receptors Regulate NMDA-Mediated Excitation in Accumbens Neurons Through A2A–D2 Receptor Heteromerization
- (2008) Karima Azdad et al. NEUROPSYCHOPHARMACOLOGY
- Positron emission tomography analysis of [11C]KW‐6002 binding to human and rat adenosine A2Areceptors in the brain
- (2008) D.J. Brooks et al. SYNAPSE
- ATP and acetylcholine, equal brethren
- (2007) Herbert Zimmermann NEUROCHEMISTRY INTERNATIONAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now